Rx only · Injection, Solution · Subcutaneous
Insulin Glargine And Lixisenatide
Brands: Soliqua 100/33 · Insulin Glargine + Lixisenatide
1 ACTIVE SUPPLIER - US
openFDA · updated weekly
US1 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
$57.087
Latest avg · Aug 19, 2026
+0%
Since Dec 17, 2025
1
Active US suppliers